04/19/2024
3:21 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
04/17/2024
11:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form EFFECT | |
04/12/2024
3:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form POS AM | |
04/12/2024
3:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form POS AM | |
04/01/2024
7:16 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2024
3:30 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
3:30 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/26/2024
4:37 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024
3:18 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
03/10/2024
11:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form EFFECT | |
03/04/2024
7:06 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/28/2024
7:11 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
10:11 AM | Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
02/15/2024
3:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B5 | |
02/15/2024
3:18 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2024
4:00 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3/A | |
01/25/2024
4:00 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3/A | |
01/22/2024
7:01 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:43 PM | Lewis William (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:40 PM | Lewis William (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/08/2024
7:21 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
7:08 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:26 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:17 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:17 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:19 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
van der Kamp Hilde Johanna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:21 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:10 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:13 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Smither John W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:14 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
4:04 PM | Downing Nicholas (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
4:09 PM | Bain Capital Life Sciences Fund II, L.P. (Reporting)
Bain Capital Life Sciences Fund III, L.P. (Reporting)
Bain Capital Life Sciences III General Partner, LLC (Reporting)
Bain Capital Life Sciences Investors II, LLC (Reporting)
Bain Capital Life Sciences Investors, LLC (Reporting)
BCIP Life Sciences Associates, LP (Reporting)
BCLS Fund III Investments GP, LLC (Reporting)
BCLS Fund III Investments, LP (Reporting)
BCLS II Investco , LLC (0001819101) (Reporting)
BCLS II Investco, LP (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
van der Kamp Hilde Johanna (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Somaiya Mayur Ian (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | LANGE LOUIS G (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | Kooij Louise Frederika (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Slootweg Hugo Alexander (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | Davidson Michael H. (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | Kling Douglas F (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | Kastelein Johannes Jacob Pieter (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad) Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide |
12/29/2023
3:30 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Topper James N (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
Smither John W (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | Audet Juliette Berangere (Reporting)
NewAmsterdam Pharma (Issuer)
NewAmsterdam Pharma Co N.V. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/19/2023
11:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form EFFECT | |
12/19/2023
3:36 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
11/13/2023
7:22 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023
7:24 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
10/23/2023
7:12 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/25/2023
7:10 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/21/2023
6:14 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/21/2023
6:18 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
09/19/2023
8:30 PM | Morningside Venture Investments Ltd (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13G/A | |
08/15/2023
3:52 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
08/14/2023
3:52 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/13/2023
11:15 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form EFFECT | |
08/07/2023
6:56 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form POS AM | |
08/07/2023
6:24 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2023
6:38 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023
3:30 PM | NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
07/07/2023
4:00 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D | |
07/07/2023
4:06 PM | Forbion Capital Fund IV Cooperatief U.A. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
06/21/2023
3:01 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2023
3:04 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
06/20/2023
3:30 PM | NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G | |
06/13/2023
4:04 PM | BCLS II Investco, LP (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
06/09/2023
8:39 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/09/2023
8:43 PM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
06/09/2023
2:47 PM | Frazier Life Sciences X, L.P. (Filed by)
NewAmsterdam Pharma (Subject)
NewAmsterdam Pharma Co N.V. (Subject)
| Form SC 13D/A | |
06/05/2023
7:50 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2023
7:00 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2023
7:11 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/23/2023
7:14 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
05/08/2023
7:33 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 424B3 | |
05/08/2023
7:30 AM | NewAmsterdam Pharma (Filer)
NewAmsterdam Pharma Co N.V. (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
